Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Higher local recurrence after skin-sparing than simple mastectomy for DCIS

Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom
Higher local recurrence after skin-sparing than simple mastectomy for DCIS ( Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom )
14 Dec 2015

Peri-operative lapatinib has profound antiproliferative effect in early breast cancer

Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom
Peri-operative lapatinib has profound antiproliferative effect in early breast cancer ( Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom )
14 Dec 2015

Guidelines and management of advanced breast cancer in limited resource settings

Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon
Guidelines and management of advanced breast cancer in limited resource settings ( Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon )
14 Dec 2015

New developments and technologies in hereditary cancer

Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015

Results of the CREATE-X trial

Dr Masakazu Toi - Kyoto University, Kyoto, Japan
Results of the CREATE-X trial ( Dr Masakazu Toi - Kyoto University, Kyoto, Japan )
14 Dec 2015

Hormonal treatments produce similar quality of life outcomes in DCIS

Prof Patricia Ganz - UCLA, Los Angeles, USA
Hormonal treatments produce similar quality of life outcomes in DCIS ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015

Treating women with endocrine-resistant HR /HER2 advanced breast cancer

Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France.
Treating women with endocrine-resistant HR /HER2 advanced breast cancer ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
11 Dec 2015

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015

Patients with DCIS receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life

Prof Patricia Ganz - UCLA, Los Angeles, USA
Patients with DCIS receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015

Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer

Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA
Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer ( Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Dec 2015

Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy

Dr Masakazu Toi - Kyoto university, Kyoto, Japan
Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy ( Dr Masakazu Toi - Kyoto university, Kyoto, Japan )
10 Dec 2015